• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (50)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Infectious Diseases, Other  • Dermatology  • Dermatologic Disorders, Other  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Adam L. Hersh, MD, PhD; Henry F. Chambers, MD; Judith H. Maselli, MSPH; Ralph Gonzales, MD, MSPH

Arch Intern Med. 2008;168(14):1585-1591.

Background  Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) has emerged as a common cause of skin and soft-tissue infections (SSTIs) in the United States. It is unknown whether this development has affected the national rate of visits to primary care practices and emergency departments (EDs) and whether changes in antibiotic prescribing have occurred.

Methods  We examined visits by patients with SSTIs to physician offices, hospital outpatient departments, and EDs using the National Ambulatory Medical Care Survey and National Hospital Ambulatory Medical Care Survey from 1997 to 2005. We estimated annual visit rates for all SSTIs and a subset classified as abscess/cellulitis. For abscess/cellulitis visits, we examined trends in characteristics of patients and clinical settings and in antibiotic prescribing.

Results  Overall rate of visits for SSTIs increased from 32.1 to 48.1 visits per 1000 population (50%; P = .003 for trend), reaching 14.2 million by 2005. More than 95% of this change was attributable to visits for abscess/cellulitis, which increased from 17.3 to 32.5 visits per 1000 population (88% increase; P < .001 for trend). The largest relative increases occurred in EDs (especially in high safety-net–status EDs and in the South), among black patients, and among patients younger than 18 years. Use of antibiotics recommended for CA-MRSA increased from 7% to 28% of visits (P < .001) during the study period. Independent predictors of treatment with these antibiotics included being younger than 45 years, living in the South, and an ED setting.

Conclusions  The incidence of SSTIs has rapidly increased nationwide in the CA-MRSA era and appears to disproportionately affect certain populations. Although physicians are beginning to modify antibiotic prescribing practices, opportunities for improvement exist, targeting physicians caring for patients who are at high risk.

Author Affiliations: Department of Pediatrics (Dr Hersh) and Division of Infectious Diseases (Dr Chambers), Department of Medicine (Ms Maselli and Dr Gonzales), University of California, San Francisco.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

In This Issue of Archives of Internal Medicine
Arch Intern Med. 2008;168(14):1484.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Prospective Investigation of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Community-Associated Methicillin-Resistant Staphylococcus aureus Infections
Miller et al.
Antimicrob. Agents Chemother. 2012;56:1084-1086.
ABSTRACT | FULL TEXT  

Skin and soft-tissue infections: Classifying and treating a spectrum
RAJAN
Cleveland Clinic Journal of Medicine 2012;79:57-66.
ABSTRACT | FULL TEXT  

Household Versus Individual Approaches to Eradication of Community-Associated Staphylococcus aureus in Children: A Randomized Trial
Fritz et al.
Clinical Infectious Diseases 2011;0:cir919v1-cir919.
ABSTRACT | FULL TEXT  

Where We Are With Community-Associated Staphylococcus aureus Prevention--And in the Meantime, What Do We Tell Our Patients?
Miller
Clinical Infectious Diseases 2011;0:cir922v1-cir922.
FULL TEXT  

Is methicillin-resistant Staphylococcus aureus replacing methicillin-susceptible S. aureus?
Mostofsky et al.
J Antimicrob Chemother 2011;66:2199-2214.
ABSTRACT | FULL TEXT  

Management of Skin and Soft Tissue Infections in Community Practice Before and After Implementing a "Best Practice" Approach: An Iowa Research Network (IRENE) Intervention Study
Daly et al.
J Am Board Fam Med 2011;24:524-533.
ABSTRACT | FULL TEXT  

Prevalence, Severity, and Treatment of Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin and Soft Tissue Infections in 10 Medical Clinics in Texas: A South Texas Ambulatory Research Network (STARNet) Study
Forcade et al.
J Am Board Fam Med 2011;24:543-550.
ABSTRACT | FULL TEXT  

Comparative Effectiveness of Antibiotic Treatment Strategies for Pediatric Skin and Soft-Tissue Infections
Williams et al.
Pediatrics 2011;128:e479-e487.
ABSTRACT | FULL TEXT  

Response: Re: Trimethoprim-sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections
Frei et al.
J Am Board Fam Med 2011;24:332-333.
FULL TEXT  

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Infectious Diseases Society of America (IDSA)
Clinical Infectious Diseases 2011;52:S397-S428.
FULL TEXT  

Skin and Soft-Tissue Infections Requiring Hospitalization at an Academic Medical Center: Opportunities for Antimicrobial Stewardship
Jenkins et al.
Clinical Infectious Diseases 2010;51:895-903.
ABSTRACT | FULL TEXT  

Skin and Soft-Tissue Infections: Modern Evolution of an Ancient Problem
Spellberg
Clinical Infectious Diseases 2010;51:904-906.
FULL TEXT  

Purulent Skin and Soft Tissue Infection: Antibiotic Selection in the Community
Kahn et al.
Journal of Primary Care & Community Health 2010;1:187-191.
ABSTRACT  

Community-Associated Methicillin-Resistant Staphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
David and Daum
Clin. Microbiol. Rev. 2010;23:616-687.
ABSTRACT | FULL TEXT  

In vitro bactericidal activity of ceftobiprole against hospital- and community-associated methicillin-resistant Staphylococcus aureus
Borbone et al.
J Antimicrob Chemother 2010;65:591-594.
FULL TEXT  

Daptomycin Versus Other Antimicrobial Agents for the Treatment of Skin and Soft Tissue Infections: A Meta-Analysis
Bliziotis et al.
The Annals of Pharmacotherapy 2010;44:97-106.
ABSTRACT | FULL TEXT  

Epidemiology of Dermatitis and Skin Infections in United States Physicians' Offices, 1993-2005
Pallin et al.
Clinical Infectious Diseases 2009;49:901-907.
ABSTRACT | FULL TEXT  

Mupirocin Resistance
Patel et al.
Clinical Infectious Diseases 2009;49:935-941.
ABSTRACT | FULL TEXT  

Antimicrobial Agents for Complicated Skin and Skin-Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-Controlled Trials
Spellberg et al.
Clinical Infectious Diseases 2009;49:383-391.
ABSTRACT | FULL TEXT  

Risk Factors for Methicillin-Resistant Staphylococcal aureus Skin and Soft Tissue Infections Presenting in Primary Care: A South Texas Ambulatory Research Network (STARNet) Study
Parchman and Munoz
J Am Board Fam Med 2009;22:375-379.
ABSTRACT | FULL TEXT  

Are Skin and Soft-Tissue Infections Becoming More Frequent?
Journal Watch Dermatology 2008;2008:3-3.
FULL TEXT  

Skin and Soft-Tissue Infections on the Rise
JWatch Infect. Diseases 2008;2008:1-1.
FULL TEXT